Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Irene Caseda
Observed names:
I Caseda,
I. Caseda,
I. Cáseda,
Irene Cáseda
Institutions:
Navarre Institute of Health Research,
Navarrabiomed
Observed institutions:
Navarre Institute of Health Research,
Navarrabiomed,
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer,
Universitat de Barcelona
ORCID:
0009-0001-7371-9310
Observed ORCID:
0009-0001-7371-9310
OpenAlex ID:
A5100286631
Organismal metabolism regulates the expansion of oncogenic PIK3CA mutant clones in normal esophagus
2024
·
Albert Herms
, Bartomeu Colom
, et al.
·
Nature Genetics
·
37
Self-sustaining long-term 3D epithelioid cultures reveal drivers of clonal expansion in esophageal epithelium
2024
·
Albert Herms
, David Fernandez-Antoran
, et al.
·
Nature Genetics
·
27
CAR-T Therapy for the Treatment of Colorectal Cancer
2025
·
Arturo Lecumberri
, Hugo Arasanz
, et al.
·
Discovery Medicine
·
7
PDF
Circulating low-density neutrophils as biomarkers of resistance to first-line anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer
2026
·
N Castro
, I Labiano
, et al.
·
Translational Oncology
·
4
The TEOGIC study project: a comprehensive characterization of early onset gastrointestinal cancer in the Northern area of Spain
2024
·
R. Vera
, N. Castro
, et al.
·
BMC Cancer
·
2
PDF
Insights into ctDNA assessment to detect minimal residual disease (MRD) in localized colorectal cancer
2026
·
Ibone Labiano
, David Guerrero-Setas
, et al.
·
Scientific Reports
·
1
PDF
6P Circulating low-density neutrophils (LDNs) are associated with resistance to immunotherapy as frontline treatment for non-small cell lung cancer (NSCLC): Updated results and proteomic characterization
2024
·
N. Castro Unanua
, O. Fontecha
, et al.
·
Annals of Oncology
·
1
3694eP Circulating myeloid cell subpopulations as predictive biomarkers of response to immune checkpoint inhibitors in metastatic clear cell renal carcinoma
2026
·
I. Gurruchaga Sotes
, I. Labiano
, et al.
·
Annals of Oncology
3813P Circulating biomarkers and immune response in small cell lung cancer
2026
·
B. Agirre Mikelarena
, M. Artola
, et al.
·
Annals of Oncology
Early-onset gastrointestinal cancer patterns in Navarre: incidence, tumour features and patient survival outcomes
2026
·
I. Caseda
, A.E. Huerta
, et al.
·
ESMO Real World Data and Digital Oncology
305P Biomarkers to guide watch-and-wait (W&W) strategies in locally advanced rectal cancer: Preliminary results from a comprehensive characterization of biological features
2026
·
A.E. Huerta
, I. Labiano
, et al.
·
Annals of Oncology
PDF
Dose optimization of immune checkpoint inhibitors for gastrointestinal malignancies
2026
·
M. Alsina
, M. Beunza-Sola
, et al.
·
ESMO Gastrointestinal Oncology
PDF
Long-term survival and biomarkers of immunotherapy in small cell lung cancer: a systematic review
2026
·
Sandra Laguna
, Amaya Sádaba
, et al.
·
Translational Lung Cancer Research
169P Early-onset gastrointestinal cancer (EOGIC) in Spain: Preliminary analysis of the prospective TEOGIC study
2025
·
I. Labiano
, A.E. Huerta
, et al.
·
Annals of Oncology
494P Preliminary data from the TEOGIC study: A comprehensive characterization of early-onset gastrointestinal cancer in Spain
2025
·
A.E. Huerta-Hernández
, I. Labiano
, et al.
·
Annals of Oncology
Correction: the TEOGIC study project: a comprehensive characterization of early onset gastrointestinal cancer in the Northern area of Spain
2024
·
R. Vera
, N. Castro
, et al.
·
BMC Cancer
Show more works
View as search
Works count:
16
Citation count:
79
H-index:
4
I10-index:
2
Year
Topic
Type